ARTICLE | Company News
PharmAthene, Siga infectious news
January 31, 2011 8:00 AM UTC
PharmAthene said the Delaware Court of Chancery concluded the trial of PharmAthene's suit claiming it has a right to an exclusive license to Siga's ST-246 smallpox antiviral as a result of Siga's ter...